This week's article and video goes out to my hospital, acute, and SNF PTs. Liver cirrhosis is a devastating disease which often ends in cancer, transplant, other comorbidities, or even death. PT plays an integral role and here's more research to back up our services in these settings!

Enjoy the video (transcript below), here's the article, and if you like what you see here then know there is more in our 3 board-approved continuing education courses on Nutrition specific for Physical Therapists. Enroll today in our new bundled course offering and save 20%, a value of $60!

   Hey, Dr. Wells here from Nutritional Physical Therapy. Just coming with a research update today. Today will be a good one for our general physical therapists as well as our acute care physical therapists.

This article is published by Hasih et al. It's published in 2024 in the Journal of Digestive Diseases and Science. Effectively, it was a meta-analysis looking at the effect of exercise on body measurements, in...

By Dr. Sean Wells, DPT, PT, OCS, ATC/L, CSCS, NSCA-CPT, CNPT, Cert-DN

Nicotinamide mononucleotide (NMN) is a molecule that has gained attention in recent years due to its potential role in enhancing longevity and healthspan. Doctors of Physical Therapy (DPTs) ought to be aware of NMN as many clients have begun taking them and are unaware of new data and legal challenges ahead. NMN is a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme involved in various cellular processes, including energy metabolism and DNA repair. Research on NMN supplementation in humans is ongoing, and while there is some promising evidence, it's important to note that the field is still evolving, and more research is needed to draw definitive conclusions.
Here is a research summary of NMN use in humans up to my knowledge cutoff date in September 2021:

1. NAD+ Levels: One of the primary reasons for interest in NMN is its potential to boost NAD+ levels in cells. NAD+ declines with age, and maintaini
...